PLASMA-LIPID FRACTIONS DURING BOPINDOLOL TREATMENT IN HYPERTENSIVE PATIENTS

被引：6

作者：

VANBRUMMELEN, P ^{[1
]}

BOLLI, P ^{[1
]}

KOOLEN, MI ^{[1
]}

STAEHELIN, HB ^{[1
]}

BUHLER, FR ^{[1
]}

机构：

[1] UNIV HOSP BASEL,DEPT MED,CH-4031 BASEL,SWITZERLAND

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1986年 / 8卷

关键词：

D O I：

10.1097/00005344-198608006-00010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S42 / S44

相关论文

共 9 条

[1] BERGLUND G, 1981, LANCET, V1, P744
[2] BURSTEIN M, 1970, J LIPID RES, V11, P583
[3] ADRENERGIC-MECHANISMS IN CONTROL OF PLASMA-LIPID CONCENTRATIONS
DAY, JL
METCALFE, J
SIMPSON, CN
[J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6323) : 1145 - 1148
[4] ANTIHYPERTENSIVE EFFICACY OF THE NEW LONG-ACTING BETA-BLOCKER BOPINDOLOL AS RELATED TO AGE
HULTHEN, UL
VANBRUMMELEN, P
AMANN, FW
BUHLER, FR
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) : 426 - 429
[5] JOHNSON BF, 1982, J CARDIOVASC PHARM, V4, pS213
[6] LEREN P, 1980, LANCET, V2, P4
[7] EFFECTS OF A NEW LONG-ACTING BETA-BLOCKER BOPINDOLOL (LT 31-200) ON BLOOD-PRESSURE, PLASMA-CATECHOLAMINES, RENIN AND CHOLESTEROL IN PATIENTS WITH ARTERIAL-HYPERTENSION
VANBRUMMELEN, P
BUHLER, FR
AMANN, FW
BOLLI, P
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (06) : 491 - 493
[8] THE RELEVANCE OF INTRINSIC SYMPATHOMIMETIC ACTIVITY FOR BETA-BLOCKER-INDUCED CHANGES IN PLASMA-LIPIDS
VANBRUMMELEN, P
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 : S51 - S55
[9] 1980, LANCET, V2, P19